miR-34a expression in serum and exosomes correlated negatively with markers of metabolic dysfunction and adiposity, with serum miR-34a levels higher than exosomal levels, suggesting its potential as a biomarker of metabolic dysfunction and insulin resistance.
Key Findings
Results
miR-34a expression negatively correlated with multiple cardiometabolic risk markers in both serum and exosomes.
Negative correlations were found with Total Cholesterol, Triglycerides, LDLc/HDLc ratio, TG/HDLc ratio, BMI, and body adiposity.
Additional negative correlations included C3, CRP, fasting insulin, HOMA-IR, HOMA-B, Chemerin, CCL2, AdipoQT, and AdipoQ-H.
miR-34a expression correlated positively with HDLc and QUICKI, both markers of favorable metabolic status.
Study population included 142 adults with mean age 36 ± 11 years, classified by body fat percentage (≥25% in men, ≥35% in women).
Results
Serum miR-34a levels were higher than exosomal miR-34a levels overall.
The difference in miR-34a abundance between compartments was noted as a consistent pattern across the study population.
Exosomes were isolated using Invitrogen® kit and characterized by cryo-TEM to confirm vesicle identity.
miR-34a expression was quantified by qRT-PCR in both serum and circulating extracellular vesicles.
The authors interpreted this difference as potentially reflecting selective packaging or differential release of miR-34a into exosomes versus free circulation.
Results
LDLc, sdLDLc, sdLDLc/LDLc ratio, TC/HDLc ratio, and fasting glucose showed opposite correlation patterns with miR-34a between serum and exosomal compartments.
These five markers displayed divergent directional correlations depending on whether serum or exosomal miR-34a was assessed.
This finding suggests that the compartment-specific packaging of miR-34a into exosomes may differentially reflect distinct aspects of lipid and glucose metabolism.
The opposite correlation patterns were notably observed for small dense LDL particles (sdLDLc) and their ratio to total LDL.
This compartment-specific divergence was highlighted as a notable finding distinguishing the two biomarker sources.
Background
Adipocyte-derived extracellular vesicles (AdEVs) and their microRNA cargo were characterized as key mediators of metabolic homeostasis and obesity-related dysfunction.
Exosomes were identified as a subtype of extracellular vesicles that transport biomolecules including nucleic acids, lipids, and proteins.
AdEVs were described as playing a crucial role in maintaining metabolic homeostasis and implicated in obesity-related dysfunction.
microRNAs were described as regulating post-transcriptional gene expression and participating in immunometabolic regulation.
The study framed miR-34a as a candidate non-invasive biomarker of adipose tissue dysfunction based on its presence in circulating exosomes.
Methods
The study classified subjects by body fat percentage thresholds of ≥25% in men and ≥35% in women to define increased fat mass.
A total of 142 adults were enrolled, with a mean age of 36 ± 11 years.
Body fat percentage thresholds were sex-specific: ≥25% for men and ≥35% for women.
Exosome isolation was performed using the Invitrogen® platform and vesicles were characterized by cryo-transmission electron microscopy (cryo-TEM).
miR-34a quantification was performed by quantitative reverse transcription PCR (qRT-PCR) in both serum and isolated exosome fractions.
Noboa-Velástegui J, Valdez-Vega R, Castro-Albarran J, Madrigal-Ruiz P, Fletes-Rayas A, Ruiz-Quezada S, et al.. (2026). Expression of Serum and Exosomal microRNA-34a in Subjects with Increased Fat Mass.. International journal of molecular sciences. https://doi.org/10.3390/ijms27010270